SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $3.33M invested in Salarius Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

87% less capital invested

Capital invested by funds: $25M → $3.33M (-$21.7M)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$74.3K
2
+$74K
3
+$64.2K
4
PAM
Panagora Asset Management
Massachusetts
+$46K
5
AG
Advisor Group
Arizona
+$42K

Top Sellers

1
-$2.26M
2
-$1.86M
3
-$1.07M
4
Ameriprise
Ameriprise
Minnesota
-$462K
5
Millennium Management
Millennium Management
New York
-$301K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
1
2